Overview

pemetrexed


'pemetrexed' can also refer to...

pemetrexed

pemetrexed

pemetrexed n.

Pemetrexed and malignant pleural mesothelioma

Clinical studies of pemetrexed and gemcitabine combinations

Pemetrexed: A multitargeted antifolate agent with promising activity in solid tumors

Dose escalation study of carboplatin–pemetrexed followed by maintenance pemetrexed for elderly patients with advanced nonsquamous nonsmall-cell lung cancer

Successful Treatment of Gastric Adenocarcinoma in a Meckel's Diverticulum with Pemetrexed Plus Carboplatin

Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers

Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines

Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM)

Gemcitabine and pemetrexed combination: the key role of the sequence of drugs administration

437PActivity of S-1 for non-small cell lung cancer pretreated with pemetrexed

Upfront association of carboplatin plus pemetrexed in patients with brain metastases of lung adenocarcinoma

An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markers

Pemetrexed plus carboplatin versus pemetrexed in pretreated patients with advanced non-squamous non-small-cell lung cancer: treating the right patients based on individualized treatment effect prediction

Maintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial

128PCOMPARISON OF EFFICACY OF PEMETREXED PLUS PLATINUM AND NON-PEMETREXED PLUS PLATINUM AS 1ST LINE CHEMOTHERAPY IN EGFR WILD TYPE NON-SQUAMOUS NSCLC

Duodenal perforation in a patient with non-small cell lung cancer receiving Pemetrexed-Cisplatin combination

 

More Like This

Show all results sharing this subject:

  • Clinical Pharmacology and Therapeutics

GO

Show Summary Details

Quick Reference

A chemotherapeutic drug (a folate antimetabolite) used to treat pleural mesothelioma and non-small-cell lung cancer. TN Alimta.

Subjects: Clinical Pharmacology and Therapeutics.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.